{"id":12295,"date":"2026-05-09T15:12:28","date_gmt":"2026-05-09T15:12:28","guid":{"rendered":"https:\/\/www.elbonifit.com\/?post_type=product&#038;p=12295"},"modified":"2026-05-09T17:56:15","modified_gmt":"2026-05-09T17:56:15","slug":"tirzepatide-10-mg","status":"publish","type":"product","link":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg","title":{"rendered":"Tirzepatide 10 mg"},"content":{"rendered":"<ul class=\"elementor-icon-list-items\">\n<li class=\"elementor-icon-list-item\"><span class=\"elementor-icon-list-text\">Physical profile: Lyophilized powder<\/span><\/li>\n<li class=\"elementor-icon-list-item\"><span class=\"elementor-icon-list-text\">This product is sold as a research chemical and not for human or animal consumption. For laboratory use by qualified professionals.<\/span><\/li>\n<li>No returns accepted<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-content-1171\" class=\"elementor-tab-content elementor-clearfix elementor-active\" role=\"region\" data-tab=\"1\" aria-labelledby=\"elementor-tab-title-1171\">\n<h2>Buy GLP-2 (TRZ) 10mg Research Peptide Online<\/h2>\n<p>This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols.<\/p>\n<h3>Peptide Classification &amp; Structural Characteristics<\/h3>\n<p>The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications.<\/p>\n<h3>Mechanism of Action in Laboratory Models<\/h3>\n<p>Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models.<\/p>\n<h3>Published Research Summary<\/h3>\n<p>Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies.<\/p>\n<h3>Specifications &amp; Handling<\/h3>\n<p>Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly.<\/p>\n<h3>GLP-2 (TRZ) Research Use Only Disclaimer<\/h3>\n<p>For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies.<\/p>\n<\/div>\n<\/div>\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-title-1172\" class=\"elementor-tab-title\" role=\"button\" data-tab=\"2\" aria-controls=\"elementor-tab-content-1172\" aria-expanded=\"false\"><a class=\"elementor-accordion-title\" tabindex=\"0\">Protocol<\/a><\/div>\n<\/div>\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-title-1173\" class=\"elementor-tab-title\" role=\"button\" data-tab=\"3\" aria-controls=\"elementor-tab-content-1173\" aria-expanded=\"false\"><a class=\"elementor-accordion-title\" tabindex=\"0\">Clinical Research<\/a><\/div>\n<\/div>\n","protected":false},"featured_media":12313,"comment_status":"open","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_joinchat":[]},"product_brand":[],"product_cat":[16],"product_tag":[],"class_list":["post-12295","product","type-product","status-publish","has-post-thumbnail","product_cat-uncategorized","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification &amp; Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_ES\" \/>\n\t\t<meta property=\"og:site_name\" content=\"BONIFIT - BIENVENIDOS\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Tirzepatide 10 mg - BONIFIT\" \/>\n\t\t<meta property=\"og:description\" content=\"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification &amp; Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"831\" \/>\n\t\t<meta property=\"og:image:height\" content=\"833\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-09T15:12:28+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-09T17:56:15+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Tirzepatide 10 mg - BONIFIT\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification &amp; Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elbonifit.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"name\":\"TIENDA\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"position\":2,\"name\":\"TIENDA\",\"item\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"name\":\"Uncategorized\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"position\":3,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg#listItem\",\"name\":\"Tirzepatide 10 mg\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"name\":\"TIENDA\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg#listItem\",\"position\":4,\"name\":\"Tirzepatide 10 mg\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"ItemPage\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg#itempage\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg\",\"name\":\"Tirzepatide 10 mg - BONIFIT\",\"description\":\"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification & Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications & Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\\u00b0C); Storage: -20\\u00b0C (long-term), 2-8\\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\",\"inLanguage\":\"es-ES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/IMG-20260509-WA0017-scaled.jpg\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg\\\/#mainImage\",\"width\":2560,\"height\":2137},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg#mainImage\"},\"datePublished\":\"2026-05-09T15:12:28+00:00\",\"dateModified\":\"2026-05-09T17:56:15+00:00\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#organization\",\"name\":\"BONIFIT\",\"description\":\"BIENVENIDOS\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cropped-bonifit.with-white-2.png\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg\\\/#organizationLogo\",\"width\":831,\"height\":833},\"image\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-10-mg\\\/#organizationLogo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/\",\"name\":\"BONIFIT\",\"description\":\"BIENVENIDOS\",\"inLanguage\":\"es-ES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Tirzepatide 10 mg - BONIFIT","description":"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification & Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications & Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","canonical_url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com#listItem","position":1,"name":"Home","item":"https:\/\/www.elbonifit.com","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","name":"TIENDA"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","position":2,"name":"TIENDA","item":"https:\/\/www.elbonifit.com\/?page_id=31","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","name":"Uncategorized"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","position":3,"name":"Uncategorized","item":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg#listItem","name":"Tirzepatide 10 mg"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","name":"TIENDA"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg#listItem","position":4,"name":"Tirzepatide 10 mg","previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","name":"Uncategorized"}}]},{"@type":"ItemPage","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg#itempage","url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg","name":"Tirzepatide 10 mg - BONIFIT","description":"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification & Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications & Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","inLanguage":"es-ES","isPartOf":{"@id":"https:\/\/www.elbonifit.com\/#website"},"breadcrumb":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2026\/05\/IMG-20260509-WA0017-scaled.jpg","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg\/#mainImage","width":2560,"height":2137},"primaryImageOfPage":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg#mainImage"},"datePublished":"2026-05-09T15:12:28+00:00","dateModified":"2026-05-09T17:56:15+00:00"},{"@type":"Organization","@id":"https:\/\/www.elbonifit.com\/#organization","name":"BONIFIT","description":"BIENVENIDOS","url":"https:\/\/www.elbonifit.com\/","logo":{"@type":"ImageObject","url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-2.png","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg\/#organizationLogo","width":831,"height":833},"image":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg\/#organizationLogo"}},{"@type":"WebSite","@id":"https:\/\/www.elbonifit.com\/#website","url":"https:\/\/www.elbonifit.com\/","name":"BONIFIT","description":"BIENVENIDOS","inLanguage":"es-ES","publisher":{"@id":"https:\/\/www.elbonifit.com\/#organization"}}]},"og:locale":"es_ES","og:site_name":"BONIFIT - BIENVENIDOS","og:type":"article","og:title":"Tirzepatide 10 mg - BONIFIT","og:description":"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification &amp; Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","og:url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg","og:image":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png","og:image:secure_url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png","og:image:width":831,"og:image:height":833,"article:published_time":"2026-05-09T15:12:28+00:00","article:modified_time":"2026-05-09T17:56:15+00:00","twitter:card":"summary_large_image","twitter:title":"Tirzepatide 10 mg - BONIFIT","twitter:description":"Buy GLP-2 (TRZ) 10mg Research Peptide Online This intermediate-capacity research formulation provides doubled potency for expanded dose-response investigations. The 10mg single-vial format supports comparative mechanistic studies across multiple dose tiers in preclinical gastrointestinal research protocols. Peptide Classification &amp; Structural Characteristics The TRZ-designated GLP-2 agonist represents a synthetic variant incorporating amino acid substitutions that enhance proteolytic resistance. Structural analysis reveals modifications positioned to optimize receptor-ligand binding kinetics while maintaining biological specificity to GLP-2 receptor isoforms. This engineering approach differentiates TRZ analogs from first-generation synthetic GLP-2 peptides in research applications. Mechanism of Action in Laboratory Models Preclinical animal studies document that GLP-2 receptor agonist administration elevates mucosal blood perfusion through endothelial nitric oxide activation. Histopathological examination reveals increased enteric neural complexity and enhanced smooth muscle contractility in treated intestinal segments. Published mechanistic research suggests these effects concentrate on proximal and mid-intestinal regions without affecting distal colonic physiology in rodent models. Published Research Summary Sigalet et al. (American Journal of Physiology, 2003) characterized GLP-2 receptor expression patterns throughout the intestinal tract, supporting regional specificity findings. Burrin et al. (Journal of Parenteral and Enteral Nutrition, 2005) extended this work using analog compounds showing dose-dependent intestinal growth responses. Contemporary research validates the continued value of 10mg-scale investigations for dose-optimization studies. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 10mg; Solvent: Sterile water or PBS recommended; Reconstitution: Cool environment preferred (15-20\u00b0C); Storage: -20\u00b0C (long-term), 2-8\u00b0C (short-term); Stability: 12-18 months if stored properly. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","twitter:image":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png"},"aioseo_meta_data":{"post_id":"12295","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"ItemPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2026-05-09 15:12:28","updated":"2026-05-18 05:04:14","ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\/?page_id=31\" title=\"TIENDA\">TIENDA<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\/?product_cat=uncategorized\" title=\"Uncategorized\">Uncategorized<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTirzepatide 10 mg\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.elbonifit.com"},{"label":"TIENDA","link":"https:\/\/www.elbonifit.com\/?page_id=31"},{"label":"Uncategorized","link":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized"},{"label":"Tirzepatide 10 mg","link":"https:\/\/www.elbonifit.com\/?product=tirzepatide-10-mg"}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12295"}],"version-history":[{"count":1,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12295\/revisions"}],"predecessor-version":[{"id":12297,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12295\/revisions\/12297"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/media\/12313"}],"wp:attachment":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12295"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=12295"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=12295"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=12295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}